Rare SARS-CoV-2 antibody development in cancer patients

SARS-CoV-2 antibody development and immunity will be crucial for the further course of the pandemic. Until now, it has been assumed that patients who are infected with SARS-CoV-2 will develop antibodies as has been the case with other coronaviruses, like MERS-CoV and SARS-CoV. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hempel, Louisa, Molnar, Jakob, Robert, Sebastian, Veloso, Julia, Trepotec, Zeljka, Englisch, Sofie, Weinzierl, Philip, Schick, Cordula, Milani, Valeria, Schweneker, Katrin, Fleischmann, Bastian, Scheiber, Josef, Gandorfer, Beate, Kleespies, Axel, Hempel, Dirk, Riedmann, Kristina, Piehler, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833493/
https://www.ncbi.nlm.nih.gov/pubmed/33500147
http://dx.doi.org/10.1053/j.seminoncol.2020.12.003

Ejemplares similares

Ejemplares similares